About Index Trending news
Analyze
Pricing
EpiTherapeutics

EpiTherapeutics

Work at EpiTherapeutics? Add yourself to this profile

EpiTherapeutics

EpiTherapeutics is developing novel innovative cancer drugs based on world leading research in epigenetics.

Elsewhere

Alexa global traffic share

Acquired by
06 May 2015
Gilead Sciences
$65,000,000
1
$65,000,000
VentureWire

Gilead to Buy EpiTherapeutics for $65M

Funding